@article{31097,
  keywords = {Stem Cell Transplantation, Rifampicin, Ofloxacin, leprosy, Doxycycline, Autologous hematopoietic stem cell transplant (HSCT)},
  author = {Salomão MC and Batista MV and Macedo MC and Sotto MN and Duarte AN and Rocha VG and Higashino HR and Costa SF},
  title = {Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe?},
  abstract = {<p>A patient with non-Hodgkin lymphoma, preparing for an autologous hematopoietic stem cell transplant (HSCT), developed leprosy. The patient was successfully treated with rifampicin, ofloxacin, and doxycycline and the HSCT was performed without complications, being the first report, to our knowledge, of leprosy in an autologous HSCT patient.</p>
},
  year = {2018},
  journal = {Transplant infectious disease : an official journal of the Transplantation Society},
  issn = {1399-3062},
  doi = {10.1111/tid.12840},
  language = {eng},
}